-
Product Insights
New![]()
Net Present Value Model: RedHill Biopharma Ltd’s RHB-204
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
Vistry Group – Redhill Residential Community – Telford and Wrekin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Vistry Group - Redhill Residential Community - Telford and Wrekin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Solum Regen – Redhill Railway Station Mixed-Use Development – Surrey
Equip yourself with the essential tools needed to make informed and profitable decisions with our Solum Regen - Redhill Railway Station Mixed-Use Development - Surrey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
![]()
RedHill Biopharma Ltd – Company Profile
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole, naloxegol, and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRX-012 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PRX-012 in Alzheimer's Disease Drug Details:PRX-012 is under development for the treatment of Alzheimer's disease. The...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CD33 NKE in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CD33 NKE in Relapsed Acute Myeloid LeukemiaDrug Details:CD33 NKE is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rongliflozin in Type 2 Diabetes
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rongliflozin in Type 2 Diabetes Drug Details: Rongliflozin (HEC-44616) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – E-7130 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.E-7130 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug Details:E-7130 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Diarrhea
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in Diarrhea Drug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Benzgalantamine in Dementia Associated With Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Benzgalantamine in Dementia Associated With Alzheimer's Disease Drug Details:Benzgalantamine (ALPHA-1062, Memogain) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome Drug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Gastroenteritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in GastroenteritisDrug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Gastritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in GastritisDrug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Esmethadone hydrochloride in Renal Failure
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Esmethadone hydrochloride in Renal Failure Drug Details: REL-1017 (D-methadone) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SAR-442257 in Refractory Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SAR-442257 in Refractory Multiple Myeloma Drug Details: SAR-442257 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Clarithromycin + Clofazimine + Rifabutin) in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Clarithromycin + Clofazimine + Rifabutin) in Crohn's Disease (Regional Enteritis) Drug Details:RHB-104, a fixed dose combination...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Opaganib in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Opaganib in Solid TumorDrug Details: Opaganib (ABC-294640) is under development for the treatment of renal interstitial...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Opaganib in Bile Duct Cancer (Cholangiocarcinoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Opaganib in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Opaganib (ABC-294640) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Talimogene Laherparepvec in Basal Cell Carcinoma (Basal Cell Epithelioma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Talimogene Laherparepvec in Basal Cell Carcinoma (Basal Cell Epithelioma) Drug Details: Talimogene laherparepvec (Imlygic) is...
-
Company Profile
![]()
Go-Ahead Group Plc – Company Profile
Go-Ahead Group plc (Go-Ahead) is a provider of passenger transportation services. The company offers transport services through various means of transport such as buses and trains. It provides bus services in London, the South-East, Brighton, Oxford, East Anglia, Plymouth, Southern and North-East England for Transport for London (TFL). The company provides also metrobuses services in Crawley, Horsham, East Grinstead, Redhill, and Reigate. It operates rails services in Norway, and Germany. Go-Ahead provides train services through Govia Thameslink Railway such as,...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.